Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-06-22

Clinical Trial Update: Treatment of Temporo-Myofascial Disorder of Muscular Origin Using Botulinum Toxin: A Prospective Study [Phase 2]

View source ↗

Summary

A Phase 2 prospective trial evaluating the use of botulinum toxin injections for Temporomandibular disorders of muscular origin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: University of Manitoba | Conditions: Temporo-Myofascial Disorder | Phase 2 | Status: UNKNOWN